IL-1RA Treatment in Patients with Acute ACL Tear and Painful Effusions

  • Lattermann, Christian (PI)

Grants and Contracts Details


We hypothesize that interleukin 1 receptor antagonist (IL-1Ra) administered intra-articularly during the early phases of acute ACL injury will provide symptomatic pain relief and decrease synovial fluid inflammatory markers and cartilage degradation.
Effective start/end date3/1/122/28/15


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.